摘要
Since December 2019,multiple cases of novel coronavirus pneumonia(COVID-19)have been identified in Wuhan,Hubei.With the spread of the epidemic,such cases have also been found in other parts of China and other countries.As an acute respiratory infectious disease,COVID-19 has been included in Class B infectious diseases prescribed in the Law of the People’s Republic of China on Prevention and Treatment of Infectious Diseases,and managed as an infectious disease of Class A.By taking a series of preventive control and medical treatment measures,the rise of the epidemic situation in China has been contained to a certain extent,and the epidemic situation has eased in most provinces,but the incidence abroad is on the rise.
